Get started
Author

Alyson L. Connor

Observed names: A.L Connor, A.L. Connor, Alyson Connor, Alyson L Connor
OpenAlex ID: A5103552334
Enteric coated HPMC capsules designed to achieve intestinal targeting
2002 · Ewart T Cole, Robert A Scott, et al. · International Journal of Pharmaceutics · 249
Development of a new engineering-based capsule for human drug absorption studies
2000 · Ian Wilding, Peter Hirst, et al. · Pharmaceutical Science & Technology Today · 122
Scintigraphic Evaluation of a Novel Colon-Targeted Delivery System (CODES™) in Healthy Volunteers
2004 · Masataka Katsuma, Shunsuke Watanabe, et al. · Journal of Pharmaceutical Sciences · 77
Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double‐Blind, Randomized, Placebo‐Controlled Phase 1 Clinical Study
2017 · Hazel Hunt, Kirsteen Donaldson, et al. · Clinical Pharmacology in Drug Development · 68
PDF
In Vitro and in Vivo Pharmacoscintigraphic Evaluation of Ibuprofen Hypromellose and Gelatin Capsules
2004 · Ewart T. Cole, Robert A. Scott, et al. · Pharmaceutical Research · 66
Assessment of Tacrolimus Absorption From the Human Intestinal Tract: Open-Label, Randomized, 4-Way Crossover Study
2014 · Daisuke Tsunashima, Akio Kawamura, et al. · Clinical Therapeutics · 63
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers
2011 · Kevin Smith, Michael Hopp, et al. · Expert Opinion on Investigational Drugs · 55
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule
2015 · Dolly A. Parasrampuria, Taro Kanamaru, et al. · The Journal of Clinical Pharmacology · 52
PDF
Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study
2021 · Tine A. Bækdal, Morten Donsmark, et al. · Clinical Pharmacology in Drug Development · 44
Scintigraphic Study to Investigate the Effect of Food on a HPMC Modified Release Formulation of UK-294,315
2008 · J. Davis, J. Burton, et al. · Journal of Pharmaceutical Sciences · 40
Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies
2013 · Hikaru Sugihara, Yuji Matsui, et al. · European Journal of Pharmaceutical Sciences · 30
Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers
2018 · Ofir Moreno, Todd Butler, et al. · Clinical Therapeutics · 28
PDF
An Oral Human Drug Absorption Study to Assess the Impact of Site of Delivery on the Bioavailability of Bevirimat
2009 · Alyson Connor, Phil Evans, et al. · The Journal of Clinical Pharmacology · 26
Phase I Clinical Trial of Repeat Dose Terameprocol Vaginal Ointment in Healthy Female Volunteers
2008 · Niharika Khanna, Richard Dalby, et al. · Sexually Transmitted Diseases · 26
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers
2010 · Armel Stockis, Maria Laura Sargentini-Maier, et al. · Clinical Therapeutics · 23
Assessment of Lumiracoxib Bioavailability from Targeted Sites in the Human Intestine Using Remotely Activated Capsules and Gamma Scintigraphy
2004 · Ian R. Wilding, Alyson L. Connor, et al. · Pharmaceutical Research · 22
Nasal Deposition of Ciclesonide Nasal Aerosol and Mometasone Aqueous Nasal Spray in Allergic Rhinitis Patients
2014 · Ivor A. Emanuel, Michael S. Blaiss, et al. · American Journal of Rhinology and Allergy · 21
PDF
Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible
2011 · Micaela B. Reddy, Alyson Connor, et al. · Biopharmaceutics & Drug Disposition · 20
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone
2015 · Avinash G. Thombre, Sheri L. Shamblin, et al. · Journal of Controlled Release · 19
A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide–simethicone formulation in man
2001 · A.L Connor, H Wray, et al. · European Journal of Pharmaceutical Sciences · 16
Location, location, Location: Gastrointestinal Delivery Site and Its Impact on Absorption
2012 · Alyson Connor · Therapeutic Delivery · 13
Optimization of LY545694 Tosylate Controlled Release Tablets Through Pharmacoscintigraphy
2012 · Evelyn D. Lobo, Mark D. Argentine, et al. · Pharmaceutical Research · 12
The assessment of human regional drug absorption of free acid and sodium salt forms of Acipimox, in healthy volunteers, to direct modified release formulation strategy
2009 · Rajeev Menon, Eugenio Cefali, et al. · Biopharmaceutics & Drug Disposition · 12
Development of oral extended release formulations of 6‐hydroxybuspirone
2012 · Sarah J. Nicholson, Peter Timmins, et al. · Biopharmaceutics & Drug Disposition · 10
Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets
2014 · John McDermott, Peter Scholes, et al. · AAPS advances in the pharmaceutical sciences series · 6
Works count: 33
Citation count: 1,139
H-index: 19
I10-index: 24
Year
Topic
Type